GSK525762
204697
Phase 1 small_molecule terminated
Quick answer
GSK525762 for Solid Tumours is a Phase 1 program (small_molecule) at GlaxoSmithKline with 1 ClinicalTrials.gov record(s).
Program details
- Company
- GlaxoSmithKline
- Indication
- Solid Tumours
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- terminated